{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:13:21Z","timestamp":1788585201245,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178194","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T03:34:22Z","timestamp":1758857662000},"page":"178194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The anticonvulsant activity of trace amine-associated receptor 1 (TAAR1) agonists involves GABAB receptors in mice"],"prefix":"10.1016","volume":"1006","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5838-4578","authenticated-orcid":false,"given":"Misato","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Fukugami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Suemaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178194_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brainres.2005.09.009","article-title":"Trace amines reduce GABAB receptor-mediated presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta","volume":"1062","author":"Berretta","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.178194_bib2","doi-asserted-by":"crossref","first-page":"20081","DOI":"10.1073\/pnas.0906522106","article-title":"The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system","volume":"106","author":"Bradaia","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178194_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.conb.2011.02.004","article-title":"GABAB receptor modulation of synaptic function","volume":"21","author":"Chalifoux","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.178194_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.toxlet.2005.07.002","article-title":"Effects of toluene on seizures induced by convulsants acting at distinct ligand-gated ion channels","volume":"160","author":"Chan","year":"2006","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2025.178194_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF02256094","article-title":"GABA-B receptor activation in the rat globus pallidus potently suppresses pentylenetetrazol-induced tonic seizures","volume":"11","author":"Chen","year":"2004","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejphar.2025.178194_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413185","article-title":"Therapeutic potential of TAAR1 agonists in schizophrenia: evidence from preclinical models and clinical studies","volume":"22","author":"Dedic","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178194_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.119.260281","article-title":"SEP-363856, a novel psychotropic agent with a unique, non-D2 receptor mechanism of action","volume":"371","author":"Dedic","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178194_bib8","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/S0028-3908(00)00050-2","article-title":"Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice","volume":"39","author":"De Sarro","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.178194_bib9","doi-asserted-by":"crossref","first-page":"15073","DOI":"10.1073\/pnas.1313505110","article-title":"GABAB autoreceptor-mediated cell type-specific reduction of inhibition in epileptic mice","volume":"110","author":"Dugladze","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178194_bib10","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/npp.2015.65","article-title":"TAAR1 modulates cortical glutamate NMDA receptor function","volume":"40","author":"Espinoza","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2025.178194_bib11","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1124\/mol.104.007427","article-title":"Trace amines depress GABAB response in dopaminergic neurons by inhibiting G-\u03b2\u03b3-gated inwardly rectifying potassium channels","volume":"67","author":"Federici","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178194_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.neuro.27.070203.144206","article-title":"Desensitization of G protein-coupled receptors and neuronal functions","volume":"27","author":"Gainetdinov","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178194_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fncel.2018.00028","article-title":"Pre- and postsynaptic activation of GABAB receptors modulates principal cell excitation in the piriform cortex","volume":"12","author":"Gerrard","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178194_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tins.2022.10.010","article-title":"Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders","volume":"46","author":"Halff","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2025.178194_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pnpbp.2003.09.026","article-title":"Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice","volume":"28","author":"Hansen","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.178194_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1992.tb01747.x","article-title":"Relative anticonvulsant effects of GABAmimetic and GABA modulatory agents","volume":"33","author":"Holland","year":"1992","journal-title":"Epilepsia"},{"issue":"257","key":"10.1016\/j.ejphar.2025.178194_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1126\/science.1321503","article-title":"The role of GABAB receptor activation in absence seizures of lethargic (lh\/lh) mice","author":"Hosford","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.178194_bib18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1911772","article-title":"A Non\u2013D2-Receptor-Binding drug for the treatment of schizophrenia","volume":"382","author":"Koblan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178194_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainresbull.2021.03.018","article-title":"The TAAR1 inhibitor EPPTB suppresses neuronal excitability and seizure activity in mice","volume":"171","author":"Kong","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2025.178194_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yebeh.2014.05.031","article-title":"The consequences of refractory epilepsy and its treatment","volume":"37","author":"Laxer","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2025.178194_bib41","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0140-6736(12)61455-X","article-title":"Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan","volume":"380","author":"Lin","year":"2012","journal-title":"The Lancet"},{"key":"10.1016\/j.ejphar.2025.178194_bib20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0896-6273(00)80381-5","article-title":"G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons","volume":"19","author":"L\u00fcscher","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2025.178194_bib21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1476-5381.1991.tb09784.x","article-title":"CGP 35348, a new GABAB antagonist, prevents antinociception and muscle\u2010relaxant effect induced by baclofen","volume":"103","author":"Malcangio","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178194_bib22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.seizure.2007.05.005","article-title":"Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice","volume":"16","author":"Mandhane","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.ejphar.2025.178194_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biopsych.2020.12.008","article-title":"TAAR1-Dependent and -Independent actions of tyramine in interaction with glutamate underlie central effects of monoamine oxidase inhibition","volume":"90","author":"Mantas","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.178194_bib24","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1152\/jn.00909.2005","article-title":"Presynaptic GABAB receptors regulate retinohypothalamic tract synaptic transmission by inhibiting voltage-gated Ca2+ channels","volume":"95","author":"Moldavan","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2025.178194_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0006-8993(86)90882-6","article-title":"Potent depressant action of baclofen on hippocampal epileptiform activity in vitro: possible use in the treatment of epilepsy","volume":"377","author":"Ogata","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.178194_bib26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1126\/science.887932","article-title":"Synaptic mechanism of pentylenetetrazole: selectivity for chloride conductance","volume":"197","author":"Pellmar","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.178194_bib27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0306-4522(00)00400-0","article-title":"Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels","volume":"101","author":"Pe\u00f1a","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.178194_bib28","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1046\/j.1471-4159.1998.70041513.x","article-title":"Presynaptic GABA(B) receptor modulation of glutamate exocytosis from rat cerebrocortical nerve terminals: receptor decoupling by protein kinase","volume":"70","author":"Perkinton","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2025.178194_bib29","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1073\/pnas.1103029108","article-title":"TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity","volume":"108","author":"Revel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178194_bib30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/mp.2012.57","article-title":"A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight","volume":"18","author":"Revel","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.178194_bib31","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3389\/fphar.2017.00987","article-title":"The case for TAAR1 as a modulator of central nervous System function","volume":"8","author":"Rutigliano","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178194_bib32","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1523\/JNEUROSCI.18-09-03138.1998","article-title":"G-protein-coupled modulation of presynaptic calcium currents and transmitter release by a GABA(B) receptor","volume":"18","author":"Takahashi","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178194_bib33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2183\/pjab.94.026","article-title":"Diversity of structure and function of GABAB receptors: a complexity of GABAB-mediated signaling","volume":"94","author":"Terunuma","year":"2018","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.ejphar.2025.178194_bib34","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1528-1157.1996.tb00641.x","article-title":"Age-specific effects of baclofen on pentylenetetrazol-induced seizures in developing rats","volume":"37","author":"Vel\u00ed\u0161kov\u00e1","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.178194_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.55782\/ane-2023-007","article-title":"An update of 4-aminopyride as a useful model of generalized seizures for testing antiseizure drugs: in vitro and in vivo studies","volume":"83","author":"Ventura-mej\u00eda","year":"2023","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.ejphar.2025.178194_bib36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/1028415X.2018.1461458","article-title":"Distinct effects of resveratrol on seizures and hyperexcitability induced by NMDA and 4-aminopyridine","volume":"22","author":"Wang","year":"2019","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178194_bib37","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/1028415X.2018.1461458","article-title":"Distinct effects of resveratrol on seizures and hyperexcitability induced by NMDA and 4-aminopyridine","volume":"22","author":"Wang","year":"2019","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178194_bib38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1113\/jphysiol.1995.sp020759","article-title":"GABAB receptor\u2010mediated presynaptic inhibition in guinea\u2010pig hippocampus is caused by reduction of presynaptic Ca2+ influx","volume":"485","author":"Wu","year":"1995","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2025.178194_bib39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/s41386-023-01779-x","article-title":"TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner","volume":"49","author":"Yang","year":"2024","journal-title":"Neuropsychopharmacology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:29:13Z","timestamp":1780201753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925009483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":41,"alternative-id":["S0014299925009483"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178194","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anticonvulsant activity of trace amine-associated receptor 1 (TAAR1) agonists involves GABAB receptors in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178194"}}